‘Top 5’ listed pharmas in R&D ratio to sales were ISU Abxis, Celltrion, Hanmi, Bukwang, Pharmicell
It was observed KOSDAQ listed pharmaceutical companies recorded a 3-times higher average growth rate of R&D expenses than the one in the KOSPI. When it comes to its ratio to sales, KOSDAQ listed pharmaceutical companies exceeded 10% while KOSPI listed pharmaceutical companies got only close to 10...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
